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Reply to: ‘‘Development and validation of a polycystic liver
disease complaint-speciﬁc assessment (POLCA) – Use
of the Delphi technique for content validation’’
this, we are convinced that we could overcome the limitations
of the ‘‘Nominal group technique’’ that in one face-to-face meet-
ing one expert inﬂuences the others. As was mentioned in the
paper, severe symptomatic PCLD is a rare disease, and such pre-
testing of the questionnaire in symptomatic PCLD patients was
not performed in order not to lose patients for the instrument’s
validation.
The validation of self-report instruments is a complex, contin-
uous process and there is obviously a need for further studies.
Further validation of the POLCA is currently being performed in
20 Belgian hospitals and data are expected within 2 years
(BE322201422560).
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JOURNAL OF HEPATOLOGYTo the Editor:
We welcome the comment by Trevisol et al. on our recent
published article ‘‘Development and validation of a Polycystic Liver
Disease Speciﬁc Assessment (POLCA)’’ [1]. We appreciate that the
authors underscored our intentions to fulﬁll the main
assumptions underlying the validation processes of a question-
naire, including content-, construct- and criterion validity; and
reliability.
The authors ask additional information concerning the
applied method for ‘‘content validation’’. In this regard, we want
to reply concisely.
In brief, patients with polycystic liver disease (PCLD) may
develop severe hepatomegaly and this may become very dis-
abling. The interpretation of complaints expressed by these
patients in terms of severity and impact on the health related
quality of life is subjective but crucial, as decisions on medical
treatment and even indication for liver transplantation are
partially based on the severity of the reported complaints and,
therefore, we developed and psychometrically validated the
POLCA.
We ﬁrst organized a general informative session in which the
conceptual framework deﬁning the item generation process and
psychometric properties. For content validation, we used the
Nominal Group technique, in which the professional judgement
by experts was guided by: an analysis of medical records from
68 patients including the transcripts of social workers and by a
review of the literature. The board consisted of experts with dif-
ferent expertise dealing with these patients: hepatologists, neph-
rologists and abdominal transplant surgeons. In addition, experts
both from a Dutch and French speaking tertiary center partici-
pated. Three consensus meetings were needed to downgrade
the initial 27 items into 16 items. Based on that list, the POLCA
questionnaire was compiled, which was again ﬁne-tuned by
phone conferences, and e-mail, to allow for comprehensiveness
and clarity. All participants approved the ﬁnal version. By doingJournal of Hepatology 2015 vol. 62 j 975–989 989
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